Radiation schedules for palliation in carcinoma esophagus

JK Science

Volumn 9, Issue 3, 2007, Pages 127-131

  Yadav, B S ^a   Kapoor, R ^a   Sharma, S C ^a   Kochhar, R ^a   Patel, F D ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Carcinoma esophagus; ILBT; Palliation; Radiation

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DYSPHAGIA; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT SCHEDULING; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME; SYMPTOM; TREATMENT DURATION;

EID: 38849091344     PISSN: 09721177     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Deshpande RK, Patil P, Sharma V, et al. Cancer of esophagus. In: Mohanti BK (ed): Textbook of Radiation Oncology Principles and Practice. B I Churchill Livingstone New Delhi 2000: 305.
2. Fisher SA, Brady LW, et al. Esophagus. In: Perez CA, Brady LW (eds), Principles and Practice of Radiation Oncology, 1998: pp 1241-43
3. Hussey HD, Barkley HT, Bleodorn FG, et al. Carcinoma of Esophagus. In: Fletcher G H (ed): Textbook of Radiotherapy, Lea and Febiger, Philadelphia, 1980: pp 689.
4. WHO hand book for reporting results of cancer treatment. Neoplasma 1980; 27(5): 607-619.
5. Cox JD, Stetz J, Pajak TF, et al. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;30; 31(5): 1341-46.
6. Bhatt ML, Mohanti BK, Kumar L, et al. Palliative treatment of non small cell lung cancer with weekly fraction radiotherapy. Ind J Cancer 2000; 37(4): 148-52.
7. Albertsson M, Ewers SB, Widmark H et al. Evaluation of the palliative effect of radiotherapy for esophageal carcinoma. Acta Oncologica 1989; 28(2): 267-70.
8. Rathi AK, Bahadur AK, Broor SL, et al. Swallowing performance after radiotherapy for squamous cell carcinoma esophagus. Tropical Gastroenterology 1997; 18(3): 95-97.
9. Kelsen DP, Ahuja R, Hopfan S, et al. Combined modality therapy of esophageal carcinoma. Cancer 1981; 48(1): 31-37.
10. Dawes PJDK, Clague MB, Dean DM, et al. Combined external beam and intracavitary radiotherapy for carcinoma of oesophagus. In: Mould RF (ed). Brachytherapy: Nucleotron. Netherlands. 1989:442-44.
11. Agrawal RK, Dawes PJ, Clague MB, et al. Combined external beam and intracavitary radiotherapy in esophageal carcinoma. Clin Oncol 1992; 4(4): 222-27.
12. Kohek PH, Pakiseh B, Glanzer H, et al. Results of irradiation treatment in patients of nonresectable esophageal cancer. Eur J Surg Oncol 1995; 21(6): 627-31.
13. Schraube P, Fitz P, Wannenmacher MF, et al. Combined endoluminal and external irradiation in inoperable esophageal carcinoma. Radiother Oncol 1997; 44(1): 45-51.
14. Datta NR, Kumar S, Nangia S, et al. A non-randomized comparison of two radiotherapy protocols in inoperable squamous cell carcinoma of the oesophagus. Clin Oncol (R Coll Radiol). 1998; 10(5):306-12.
15. Hujala K, Sipila J, Minn H et al. Combined external and intraluminal radiotherapy in the treatment of advanced oesophageal cancer Radiother Oncol 2002; 64(1):41-45.
16. Sharma V, Mahantshetty U, Dinshaw KA, et al. Palliation of advanced recurrent esophageal carcinoma with high dose rate brachytherapy. Int J Radiation Oncology Biol Phys 2002; 52(2): 310-15.